Pharmacy News

Sandra Leal Amplifying Our Voices

Sandra Leal, APhA President, 2021–2022 shared words of gratitude as well as the importance and value of advocacy in her #APhA2022 Presidential Speech, “Amplifying Our Voice.”

Could famotidine reduce COVID-19 symptoms?

According to outpatient clinical trial results recently published in Gut, the common heartburn medication Pepcid (famotidine) could improve the recovery of symptomatic patients diagnosed with COVID-19.

Most physicians unable to estimate patients’ out-of-pocket costs: How pharmacists can help

An estimated one in three Americans struggles to afford their medical bills. Who do they go to for help finding solutions to this common problem? “My physician” is the typical answer. But according to a recent study published in JAMA, few are equipped to help.

CDC makes the case for pharmacists’ reimbursement given expanding roles

The health care disruptions created by the public health emergency have revived interest in identifying opportunities to optimize pharmacists’ roles.

FDA expands access to mifepristone to mail-order and community pharmacies

In December 2021, FDA permanently lifted a major restriction on medication abortions that had been temporarily lifted earlier in the COVID-19 pandemic. Prior to the pandemic, patients were required to pick up mifepristone in person from a certified prescriber. In 2020, FDA temporarily lifted this in-person requirement. The new change from FDA will permanently allow any certified mail-order or brick-and-mortar pharmacy to dispense the drug with a prescription.